Talc-containing makeup products for tweens sold by retailers Claire’s and Justice tested positive for cancer-causing asbestos, the Food and Drug Administration (FDA) said in a news release, confirming reports from 2017 that led to the recall of several products.
The FDA first became aware of reports of asbestos contamination in certain cosmetic products sold by Claire’s and Justice in September 2017. Since testing had been done by third-party laboratories, the FDA conducted its own testing to confirm the results were accurate.
In the interim, Justice voluntarily recalled eight products, including Just Shine Shimmer Powder, Just Shine Bronzer Brush, Makeup Palette Pinks, Blues and Glitter Cream, and Eye Shadow Palette Cool Pinks, Eye Shadow and Glitter Cream.
Three months later, Claire’s removed from stores its Ultimate Mega Make Up Set, Metallic Hot Pink Glitter 48-Piece Makeup Set, Bedazzled Rainbow Heart Makeup Set, Rainbow Bedazzled Star Make Up Set, Rainbow Glitter Heart Shaped Makeup Set, Mint Glitter Make Up Set, Rainbow Bedazzled Rectangle Make Up Set, and Pink Glitter Palette with Eyeshadow & Lip Gloss.
Results from the FDA’s round of testing confirmed the presence of asbestos in three of the product samples collected from Claire’s and one of the product samples collected from Justice. All suspect Justice products, including the one that tested positive for asbestos, were previously recalled from the market in 2017.
The FDA asked Claire’s to recall the three products that tested positive for asbestos, but the company refused. Since the FDA does not have the authority to mandate a recall, the agency issued a Safety Alert to warn consumers not to use three of Claire’s products because they are contaminated with cancer-causing asbestos:
- Claire’s Eye Shadows – Batch No./Lot No: 08/17;
- Claire’s Compact Powder – Batch No./Lot No: 07/17;
- Claire’s Contour Palette – Batch No/Lot No: 04/17.
Asbestos exposure can cause serious health conditions including lung cancer and mesothelioma, a rare but deadly form of cancer that develops in the lining of the lungs, abdomen or chest.
Claire’s filed for Chapter 11 bankruptcy last year, which protects it against liability.
FDA News Release
FDA Safety Alert